BioAtla (BCAB) Competitors $0.41 -0.04 (-9.03%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.42 +0.01 (+3.16%) As of 02/21/2025 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BCAB vs. ANL, PMVP, EPIX, MURA, TLSA, BGM, TNYA, GNTA, ZIVO, and FBRXShould you be buying BioAtla stock or one of its competitors? The main competitors of BioAtla include Adlai Nortye (ANL), PMV Pharmaceuticals (PMVP), ESSA Pharma (EPIX), Mural Oncology (MURA), Tiziana Life Sciences (TLSA), Qilian International Holding Group (BGM), Tenaya Therapeutics (TNYA), Genenta Science (GNTA), ZIVO Bioscience (ZIVO), and Forte Biosciences (FBRX). These companies are all part of the "pharmaceutical products" industry. BioAtla vs. Adlai Nortye PMV Pharmaceuticals ESSA Pharma Mural Oncology Tiziana Life Sciences Qilian International Holding Group Tenaya Therapeutics Genenta Science ZIVO Bioscience Forte Biosciences BioAtla (NASDAQ:BCAB) and Adlai Nortye (NASDAQ:ANL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk. Which has better valuation & earnings, BCAB or ANL? Adlai Nortye has higher revenue and earnings than BioAtla. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioAtlaN/AN/A-$123.46M-$1.70-0.24Adlai Nortye$5M16.20-$104.87MN/AN/A Which has more volatility and risk, BCAB or ANL? BioAtla has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Adlai Nortye has a beta of -1.42, suggesting that its share price is 242% less volatile than the S&P 500. Does the MarketBeat Community believe in BCAB or ANL? BioAtla received 17 more outperform votes than Adlai Nortye when rated by MarketBeat users. However, 100.00% of users gave Adlai Nortye an outperform vote while only 67.57% of users gave BioAtla an outperform vote. CompanyUnderperformOutperformBioAtlaOutperform Votes2567.57% Underperform Votes1232.43% Adlai NortyeOutperform Votes8100.00% Underperform VotesNo Votes Do insiders and institutionals have more ownership in BCAB or ANL? 77.2% of BioAtla shares are owned by institutional investors. Comparatively, 35.2% of Adlai Nortye shares are owned by institutional investors. 11.5% of BioAtla shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts rate BCAB or ANL? BioAtla currently has a consensus target price of $6.00, suggesting a potential upside of 1,370.23%. Adlai Nortye has a consensus target price of $9.00, suggesting a potential upside of 310.02%. Given BioAtla's higher probable upside, research analysts clearly believe BioAtla is more favorable than Adlai Nortye.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioAtla 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Adlai Nortye 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor BCAB or ANL? In the previous week, BioAtla's average media sentiment score of 0.00 equaled Adlai Nortye'saverage media sentiment score. Company Overall Sentiment BioAtla Neutral Adlai Nortye Neutral Is BCAB or ANL more profitable? Adlai Nortye's return on equity of 0.00% beat BioAtla's return on equity.Company Net Margins Return on Equity Return on Assets BioAtlaN/A -187.30% -96.33% Adlai Nortye N/A N/A N/A SummaryAdlai Nortye beats BioAtla on 7 of the 12 factors compared between the two stocks. Get BioAtla News Delivered to You Automatically Sign up to receive the latest news and ratings for BCAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCAB vs. The Competition Export to ExcelMetricBioAtlaBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.69M$3.11B$5.84B$9.15BDividend YieldN/A1.55%4.75%3.85%P/E Ratio-0.2427.4925.4719.00Price / SalesN/A329.47447.5876.30Price / CashN/A168.8738.0134.83Price / Book0.283.687.644.62Net Income-$123.46M-$71.72M$3.18B$245.85M7 Day Performance-12.16%-2.50%-1.99%-2.68%1 Month Performance-18.13%-0.32%-0.42%-2.19%1 Year Performance-82.71%-12.32%16.51%12.84% BioAtla Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCABBioAtla2.7082 of 5 stars$0.41-9.0%$6.00+1,370.2%-83.1%$21.69MN/A-0.2460ANLAdlai Nortye1.3759 of 5 stars$2.01-4.3%$9.00+347.8%-70.8%$74.17M$5M0.00127PMVPPMV Pharmaceuticals2.5519 of 5 stars$1.43-0.7%$5.50+284.6%-16.6%$74.00MN/A-1.4350EPIXESSA Pharma3.1186 of 5 stars$1.66-1.8%$9.50+472.3%-79.0%$73.69MN/A-2.5950MURAMural Oncology3.5948 of 5 stars$4.28-4.3%$16.00+273.8%-13.6%$72.85MN/A-0.47119TLSATiziana Life Sciences0.78 of 5 stars$0.69+1.5%N/A+56.1%$72.74MN/A0.008BGMQilian International Holding GroupN/A$9.93-5.5%N/AN/A$71.79M$25.10M0.00298TNYATenaya Therapeutics2.8827 of 5 stars$0.90-7.0%$17.33+1,832.2%-79.1%$71.07MN/A-0.62110Gap UpGNTAGenenta Science2.6269 of 5 stars$3.88+1.3%$25.00+544.3%-10.0%$70.97MN/A0.007ZIVOZIVO BioscienceN/A$19.00-3.8%N/A+201.3%$70.49M$30,000.00-3.8910High Trading VolumeFBRXForte Biosciences3.464 of 5 stars$11.03-7.4%$23.58+113.8%+39,891.3%$70.48MN/A-0.685Options VolumeNews Coverage Related Companies and Tools Related Companies ANL Alternatives PMVP Alternatives EPIX Alternatives MURA Alternatives TLSA Alternatives BGM Alternatives TNYA Alternatives GNTA Alternatives ZIVO Alternatives FBRX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BCAB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAtla, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioAtla With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCAB Stock Alerts